Dilip Shanghvi founded Sun Pharma with ₹10,000 and built it into India’s largest pharmaceutical company. With a focus on generics and global acquisitions—including Ranbaxy—the Shanghvi family reshaped access to affordable medicine worldwide. Quiet, disciplined, and deeply science-led, their journey is a lesson in strategic patience and consistent performance. Today, their sights are set on innovation-led therapies and healthcare impact.